We also showed that FKBP5 expression level could potentially be used as a biomarker for treatment selection of gemcitabine with or without Akt inhibitors using pancreatic cancer xenograft mice [11]. This evidence concerns the gene FKBP5 and familial pancreatic carcinoma.